Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)

Von Amsberg, GunhildEmmenegger, UrbanRobbrecht, Debbie G. J.Arslan, CagatayMehra, NivenGonzalez-Billalabeitia, EnriqueYu, Evan Y.2025-09-252025-09-2520251743-75551743-7563https://hdl.handle.net/20.500.14365/6470eninfo:eu-repo/semantics/closedAccessPhase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)Conference Object